Bio2Bedside Featured Biotech MaxCyte MaxCyte is a U.S.-based biotechnology company that develops and commercializes cell-engineering technologies used in both research and therapeutic manufacturing. US-Based Cell Engineering LNP-Based Delivery Electroporation Home Page MaxCyte: Episode Overview We discuss why viral and non-viral…
Bio2Bedside Featured Biotech NAYA Therapeutics Naya Therapeutics is a US-based biotech developing NK cell engagers and targeted alpha radiopharmaceuticals to treat hepatocellular carcinoma and other solid tumors. US-Based Clinical-Stage Cancer Therapy NK Cell Engager Radiopharmaceutical Targeted Alpha Therapy NAYA…
Bio2Bedside Featured Biotech Neobe Therapeutics Neobe is a UK-based biotech engineering tumor-targeting bacterial therapies to dismantle fibrotic barriers in solid tumors. UK-Based Preclinical Bacteria-Based Therapeutics Ask us anything about Neobe www.neobetherapeutics.com Neobe Tx: Episode Overview Check out our episode overview…
Bio2Bedside Featured Biotech KiraGen Bio KiraGen Bio is developing multi-plex gene-edited CAR-T cell therapies for solid tumors. US-Based Preclinical CAR-Based Cell Therapy Cell Therapy T Cell Therapy Allogeneic Multi-Genic Cell Therapy www.kiragenbio.com Key Highlights Introducing, KiraGen Bio: The Who,…
